CLINICAL TRIALS PROFILE FOR AMIDATE
✉ Email this page to a colleague
All Clinical Trials for AMIDATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01823328 ↗ | Ketamine Versus Etomidate for Rapid Sequence Intubation | Completed | Hennepin Healthcare Research Institute | Phase 4 | 2013-09-01 | The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI). |
NCT01823328 ↗ | Ketamine Versus Etomidate for Rapid Sequence Intubation | Completed | Minneapolis Medical Research Foundation | Phase 4 | 2013-09-01 | The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI). |
NCT02453373 ↗ | Helping Stroke Patients With ThermoSuit Cooling | Recruiting | Geisinger Clinic | N/A | 2017-01-25 | The aim of this study is to assess the feasibility of using the Life Recovery Systems ThermoSuit Device to induce therapeutic hypothermia (32-34°C) in victims of ischemic stroke. This feasibility clinical study will enroll a total of 30 patients with acute ischemic stroke at four clinical centers. Subjects will receive hypothermia plus conventional therapy (such as IV-tPA and/or neurothrombectomy therapies if indicated). Endpoints will include feasibility of cooling, adverse events, and neurological recovery in comparison with matched historical controls. |
NCT02453373 ↗ | Helping Stroke Patients With ThermoSuit Cooling | Recruiting | Tulane University School of Medicine | N/A | 2017-01-25 | The aim of this study is to assess the feasibility of using the Life Recovery Systems ThermoSuit Device to induce therapeutic hypothermia (32-34°C) in victims of ischemic stroke. This feasibility clinical study will enroll a total of 30 patients with acute ischemic stroke at four clinical centers. Subjects will receive hypothermia plus conventional therapy (such as IV-tPA and/or neurothrombectomy therapies if indicated). Endpoints will include feasibility of cooling, adverse events, and neurological recovery in comparison with matched historical controls. |
NCT02453373 ↗ | Helping Stroke Patients With ThermoSuit Cooling | Recruiting | Life Recovery Systems | N/A | 2017-01-25 | The aim of this study is to assess the feasibility of using the Life Recovery Systems ThermoSuit Device to induce therapeutic hypothermia (32-34°C) in victims of ischemic stroke. This feasibility clinical study will enroll a total of 30 patients with acute ischemic stroke at four clinical centers. Subjects will receive hypothermia plus conventional therapy (such as IV-tPA and/or neurothrombectomy therapies if indicated). Endpoints will include feasibility of cooling, adverse events, and neurological recovery in comparison with matched historical controls. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AMIDATE
Condition Name
Clinical Trial Locations for AMIDATE
Trials by Country
Clinical Trial Progress for AMIDATE
Clinical Trial Phase
Clinical Trial Sponsors for AMIDATE
Sponsor Name